D-0086-2026 Class II Ongoing

Recalled by GenoGenix LLC — Boca Raton, FL

FDA drug recall D-0086-2026 was initiated by GenoGenix LLC on Jul 30, 2025 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing.

Recall details

Product Type
Drugs
Report Date
Oct 15, 2025
Initiation Date
Jul 30, 2025
Voluntary/Mandated
Voluntary: Firm initiated

Product description

BPC-157/Thymosin Beta-4 for Injection, a) 10/10mg, b) 15/15mg, c) 15mg/15mg, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for CELIA Health, Extension Health and Medical Health Institute (MHI).

Reason for recall

Lack of Assurance of Sterility

Distribution pattern

US Nationwide.

Code information

Lot#: GG020525-001, GG060525-001, GG062625-004, within expiry.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0086-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0086-2026. Report a data issue: hello@regdatalab.com.